These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series. Blumbach J; Dürckheimer W; Ehlers E; Fleischmann K; Klesel N; Limbert M; Mencke B; Reden J; Scheunemann KH; Schrinner E J Antibiot (Tokyo); 1987 Jan; 40(1):29-42. PubMed ID: 3558116 [TBL] [Abstract][Full Text] [Related]
64. The use of ceftriaxone for bacterial pneumonia in pediatric patients. Congeni B Clin Pediatr (Phila); 1990 Nov; 29(11):640-1. PubMed ID: 2265515 [No Abstract] [Full Text] [Related]
65. A study of the relationship between dose and pharmacokinetics of ceftriaxone. Findlay CD; Brown RM; Allcock JE; Lowe PA; Wise R J Antimicrob Chemother; 1982 Jan; 9(1):57-62. PubMed ID: 6277840 [No Abstract] [Full Text] [Related]
70. Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance. McNamara PJ; Gibaldi M; Stoeckel K Eur J Clin Pharmacol; 1983; 25(3):407-12. PubMed ID: 6313380 [TBL] [Abstract][Full Text] [Related]
71. [Experimental and clinical study of Rifomycin SV]. Kiss J; Nagy M; Faragó E; Fábián E Orv Hetil; 1968 Sep; 109(36):1981-3. PubMed ID: 5714844 [No Abstract] [Full Text] [Related]
72. Effect of synnematin B treatment of Salmonella infections in mice and chicks. OLSON BH; JENNINGS JC Antibiot Chemother (Northfield); 1954 Jan; 4(1):11-7. PubMed ID: 24542868 [No Abstract] [Full Text] [Related]
73. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections]. Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746 [TBL] [Abstract][Full Text] [Related]
74. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638 [TBL] [Abstract][Full Text] [Related]